Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Chinese AI System Designed to Predict Diabetes Years in Advance

By HospiMedica International staff writers
Posted on 24 Sep 2018
4 Paradigm (Beijing, China), a technology company, is working with Ruijin Hospital (Shanghai, China) to develop a new artificial intelligence (AI) system that will help them to identify patients at risk of developing diabetes up to 15 years in advance. More...
The model named Ruining Knows Sugar, or Ruining Zhitang in Chinese, has achieved an accuracy rate of 88% in tests.

Designed to identify those most at risk of developing type 2 diabetes within the next three years, the system also provided risk forecasts for the next nine and 15 years as a reference. For the tests, the new system used medical information from 170,000 individuals from across the country, some of who had diabetes and others did not. The data collected by the hospital’s diabetes research team between 2010 and 2013 included gender, height, weight, blood sugar levels, smoking and drinking history, and education levels. The AI algorithm then used that information to make its predictions and “learned” from the results.

The use of AI to help predict and monitor diabetes is growing. For instance, in June 2018, medical device company Medtronic along with IBM Waston Health released its Sugar.IQ app, which evaluates how a user’s blood sugar levels respond to variables such as food intake, insulin dosing and other daily routines.

Related Links:
4 Paradigm
Ruijin Hospital

Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Resorbable Bovine Collagen Membrane
GenDerm
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Amplatzer Paraclose PVL Occluder is a minimally invasive device for paravalvular leak closure, offering an alternative to repeat open-heart surgery. (Photo courtesy of Abbott)

FDA Approves First Transcatheter Device for Paravalvular Leak Closure

Paravalvular leak is a backflow of blood around a surgical heart valve that can follow valve replacement, causing heart failure symptoms or hemolysis. These leaks occur in 7%–17% of mitral valve replacements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

Video-Based Support Helps Older Adults Clarify Kidney Disease Treatment Preferences

Advanced chronic kidney disease (CKD) involves progressive loss of kidney function that can lead to kidney failure and difficult treatment decisions. For older adults, these decisions may include choosing... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

AI-Guided Echocardiography Enables Mobile Cardiac Imaging in Rural Communities

Echocardiography uses ultrasound to provide real-time images of cardiac structure and function, but access can be limited in rural communities where testing often depends on expert sonographers, imaging... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.